PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 43 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,380 | -70.5% | 267,599 | 0.0% | 0.00% | – |
| Q1 2024 | $18,250 | +166.9% | 267,599 | -8.0% | 0.00% | – |
| Q4 2023 | $6,838 | +25225.9% | 290,999 | -22.4% | 0.00% | -100.0% |
| Q3 2023 | $27 | +17.4% | 374,998 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $23 | +53.3% | 374,998 | 0.0% | 0.00% | – |
| Q1 2023 | $15 | -6.2% | 374,998 | 0.0% | 0.00% | – |
| Q4 2022 | $16 | – | 374,998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atalaya Capital Management LP | 424,867 | $8,497 | 0.02% |
| PERISCOPE CAPITAL INC. | 427,634 | $8,595 | 0.00% |
| Q Global Advisors, LLC | 170,785 | $3 | 0.00% |
| CANTOR FITZGERALD, L. P. | 441,048 | $8,865 | 0.00% |
| MMCAP International Inc. SPC | 375,000 | $7,538 | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 829,598 | $16,592 | 0.00% |
| Silver Rock Financial LP | 12,224 | $246 | 0.00% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 50,000 | $1,005 | 0.00% |
| Walleye Trading LLC | 88,074 | $1,770 | 0.00% |
| Ancora Advisors LLC | 2,500 | $50 | 0.00% |